Original paper
SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer
Abstract
Non-small cell lung cancer (NSCLC) remains a lethal disease despite many proposed treatments. Recent studies have indicated that epigenetic therapy, which targets epigenetic effects, might be a new therapeutic methodology for NSCLC. However, it is not clear which objects (e.g., genes) this treatment specifically targets. Secreted frizzled-related proteins (SFRPs) are promising candidates for epigenetic therapy in many cancers, but there have...
Paper Details
Title
SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer
Published Date
Aug 1, 2016
Journal
Volume
9
Issue
S1